PLIANT THERAPEUTICS
Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Pliant's lead product candidate, PLN-74809, is an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins that it is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or PSC. PLN-74809 has received Orphan Drug Designation from the U.S. Food and Drug Administration for both ... IPF and PSC. Pliant is currently recruiting two Phase 2a trials of PLN-74809 for the treatment of IPF and plans to initiate a Phase 2a trial in PSC in the second half of 2020. Pliant's second product candidate, PLN-1474, is a small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis, or NASH, which Pliant has partnered with Novartis. PLN-1474 is currently undergoing a Phase 1 trial. In addition to clinical stage programs, Pliant currently has two preclinical programs targeting oncology and muscular dystrophies.
PLIANT THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical Recruiting Therapeutics
Founded:
2015-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.pliantrx.com
Total Employee:
101+
Status:
Active
Contact:
(910)509-3977
Email Addresses:
[email protected]
Total Funding:
407.45 M USD
Technology used in webpage:
SPF Content Delivery Network Microsoft Exchange Online Office 365 Mail IPv6 JsDelivr YouTube Google BootstrapCDN Google Cloud
Similar Organizations
Ritter Pharmaceuticals
Ritter Pharmaceuticals discovers and commercializes treatments for gastrointestinal diseases.
Repare Therapeutics
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
Receptos
Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
NanoCellect Biomedical
NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.
Virion Therapeutics
Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.
Viridian Therapeutics
Viridian Therapeutics focuses in advancing new treatments for patients with diseases that are underserved by today’s therapies.
MDI Therapeutics
MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.
Mapp Biopharmaceutical
Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases.
Lyra Therapeutics
Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases.
Applied Therapeutics
Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.
AgomAb Therapeutics
AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.
Agilis Biotherapeutics
Agilis Biotherapeutics designs and engineers DNA-based therapeutics for genetic disorders.
AcelRx Pharmaceuticals
AcelRx Pharmaceuticals focuses on the development and commercialization of therapies for the treatment of pain and other conditions.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Annexon Biosciences
Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.
Apexian Pharmaceuticals
Apex Therapeutics develops and commercializes pharmaceuticals for the treatment of cancer and ocular diseases.
AquaBounty Technologies
AquaBounty Technologies is a biotechnology company that focuses on improving productivity in commercial aquaculture.
AN2 Therapeutics
AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Alkermes
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
Airway Therapeutics
Airway Therapeutics focuses on pulmonary research program of Cincinnati Children’s Hospital Medical Center for further development.
AsclepiX Therapeutics
AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Allena Pharmaceuticals
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Allogene Therapeutics
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Elcelyx Therapeutics
Elcelyx Therapeutics is developing nutrient sensing-based products for weight management and obesity-related metabolic disorders.
Elgia Therapeutics
Elgia Therapeutics is a biopharmaceutical company.
Baudax Bio
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
Fountain Therapeutics
Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.
Fibrocor Therapeutics
Fibrocor Therapeutics focuses on developing disease modifying therapeutics in fibrosis.
Fortress Biotech
Fortress Biotech is biopharmaceutical company focused on acquiring, developing, and commercializing drugs and drug candidates.
Theragene Pharmaceuticals
Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.
Tavotek Biotherapeutics
Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines.
Jecure Therapeutics
Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis.
Kezar Life Sciences
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
Koya Medical
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Kodiak Sciences
Kodiak is designing and developing novel therapies for the treatment of retinal disease.
858 Therapeutics
858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology.
Sarepta Therapeutics
Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.
SkylineDx
SkylineDx is a pioneer in the field of molecular diagnostics through developing and commercializing innovative, signature-based diagnostics.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Sorriso Pharmaceuticals
Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.
Synaps Dx
Synaps Dx focuses on the research, development and commercialization for neurodegenerative disorders including Alzheimer’s Disease.
Somru Bioscience
Somru Bioscience is an emerging biotechnology company dedicated to developing breakthrough antibody technology for research.
Stoke Therapeutics
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment.
Synta Pharmaceuticals
Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.
Dignify Therapeutics
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
Aerami Therapeutics
Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals focuses on improving kinase inhibitor treatments.
Horizon Pharma
Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.
IOmx Therapeutics
iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics.
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Iconic Therapeutics
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.
Genalyte
Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.
Galena Biopharma
Galena Biopharma, Inc. is focused on discovering, developing and commercializing innovative therapies.
GW Pharmaceuticals
GW Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics.
Gain Therapeutics
Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.
Gene Sciences, Inc.
Gene Sciences Inc. is developing novel DNA targeted therapeutics for the treatment of human genetic diseases.
OS Therapies
OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for Osteosarcoma.
Ocumension Therapeutics
Ocumension Therapeutics is a pharmaceutical platform dedicated to identifying, developing, and commercializing ophthalmic therapies.
Oncternal Therapeutics
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers.
Zogenix
Zogenix develops and commercializes products for the treatment of central nervous system disorders and pain.
Zavante Therapeutics
Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.
Castle Creek Biosciences
Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.
Catalyst Pharmaceuticals Partners
Catalyst is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs
Corvidia
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
Critical Diagnostics
Critical Diagnostics is engaged in the R&D and commercialization of novel biomarkers in cardiovascular diseases.
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Cytimmune Sciences
CytImmune Sciences focuses on the discovery, development and commercialization of multifunctional, tumor-targeted therapies.
Cardioxyl Pharmaceuticals
Cardioxyl Pharmaceuticals discovers, develops and commercializes therapies for the treatment of cardiovascular disease.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Apollomics
Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Point Biopharma
Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.
Galectin Therapeutics
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
Palvella Therapeutics
Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Pharmazz
Pharmazz is a Biopharmaceutical Company.
Phanes Therapeutics
Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Helomics
Helomics provides comprehensive tumor profiling utilizing proprietary tissue-based live cell and fixed cell products and services.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Novartis Institutes for Biomedical Research
Novartis Institutes for Biomedical Research investment in Series C - Pliant Therapeutics
Agent Capital
Agent Capital investment in Series C - Pliant Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Pliant Therapeutics
Logos Capital
Logos Capital investment in Series C - Pliant Therapeutics
Eventide
Eventide investment in Series C - Pliant Therapeutics
Schroder Adveq
Schroder Adveq investment in Series C - Pliant Therapeutics
S-Cubed Capital
S-Cubed Capital investment in Series C - Pliant Therapeutics
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series C - Pliant Therapeutics
Redmile Group
Redmile Group investment in Series C - Pliant Therapeutics
Menlo Ventures
Menlo Ventures investment in Series C - Pliant Therapeutics
Official Site Inspections
http://www.pliantrx.com Semrush global rank: 1.67 M Semrush visits lastest month: 14.67 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
